Identification and characterization of A-105972, an antineoplastic agent

Cancer Research

Volumn 61, Issue 4, 2001, Pages 1486-1492

  Wu Wong, Jinshyun R ^a   Alder, Jeffery D ^a   Alder, Lisa ^a   Burns, David J ^a   Han, Edward K H ^a   Credo, Bruce ^a   Tahir, Stephen K ^a   Dayton, Brian D ^a   Ewing, Patricia J ^a   Chiou, William J ^a  

^a ABBOTT LABORATORIES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

A 105972; ANTINEOPLASTIC AGENT; COLCHICINE; DOXORUBICIN; PACLITAXEL; PROTEIN BCL 2; PROTEIN P53; TUBULIN; UNCLASSIFIED DRUG; VINBLASTINE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BREAST CANCER; CANCER CELL CULTURE; CANCER RESISTANCE; CELL CYCLE; CENTRAL NERVOUS SYSTEM TUMOR; COLON CANCER; CONTROLLED STUDY; DRUG CYTOTOXICITY; DRUG POTENCY; FEMALE; HUMAN; HUMAN CELL; LEUKEMIA P 388; LIVER CANCER; LUNG CANCER; MALIGNANT NEOPLASTIC DISEASE; MELANOMA B16; MOUSE; MULTIDRUG RESISTANCE; NONHUMAN; POLYACRYLAMIDE GEL ELECTROPHORESIS; PRIORITY JOURNAL; PROSTATE CANCER; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION;

ANIMALS; ANTINEOPLASTIC AGENTS; APOPTOSIS; CELL CYCLE; DRUG SCREENING ASSAYS, ANTITUMOR; FEMALE; HUMANS; INHIBITORY CONCENTRATION 50; LEUKEMIA P388; MICE; MICE, INBRED BALB C; MICE, INBRED C57BL; MICE, INBRED DBA; MICROTUBULES; OXADIAZOLES; PHOSPHORYLATION; PROTEIN BINDING; PROTO-ONCOGENE PROTEINS C-BCL-2; TUBULIN; TUMOR CELLS, CULTURED;

EID: 0035866356     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (15)

1. Multidrug resistance in human tumors: Molecular diagnosis and clinical significance
2. Therapeutic strategies involving the multidrug resistance phenotype: The MDRI gene as target, chemoprotectant, and selectable marker in gene therapy
3. Multidrug resistance mediated by the ATP-binding cassette transporter protein MRP
4. The drug resistance-related protein LRP is the human major vault protein
5. Characterization of the p53 tumor suppressor pathway in cell lines of the National Cancer Institute anticancer drug screen and correlations with the growth-inhibitory potency of 123 anticancer agents
6. Direct determination of endothelin receptor antagonist levels in plasma using a scintillation proximity assay
7. Microtubule assembly in the absence of added nucleotides
8. The National Cancer Institute: Cancer drug discovery and development program
9. Some practical considerations and applications of the National Cancer Institute In Vitro Anticancer Drug Discovery Screen
10. Microtubule dynamics: Taking aim at a moving target
11. Microtubules and actin filaments: Dynamic targets for cancer chemotherapy
12. Addition of colchicine-tubulin complex to microtubule ends: The mechanism of substoichiometric colchicine poisoning
13. The effect of anti microtubule agents on signal transduction pathways of apoptosis: A review
14. Mechanism of mitotic block and inhibition of cell proliferation by Taxol at low concentrations
15. Microtubule treadmilling: What goes around comes around